Sildenafil
Product Images NDC 53217-198
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 53217-198). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image Description (Sildenafil 10)
Structure (Sildenafil 2)
Figure2 (Sildenafil 3)
The given text provides drug interaction recommendations for various medications with Sildenafil. The recommendations provide instructions on whether or not a dose adjustment is required for the corresponding medication. Atorvastatin, Azithromycin, Bosentan, Erythromycin, and Saquinavir require no dose adjustment, while Cimetidine and Oral Contraceptives require adjustment. Coadministration of Ritonavir is not recommended. The text also presents a graph depicting the change in drug fold relative to Sildenafil alone.*
Figure3 (Sildenafil 4)
This text provides information on drug interactions with Acenocoumarol, a medication used as a blood-thinning agent. It lists other drugs, including Aspirin, Atorvastatin, Bosentan, and Ritonavir, among others, that may interact with Acenocoumarol. The text suggests whether or not dose adjustments are needed and provides fold change and recommendation guidance. It includes important terms such as INR (international normalized ratio), AUC (area under the curve), and Cmax (maximum concentration).*
Figure4 (Sildenafil 5)
Figure5 (Sildenafil 6)
Figure6 (Sildenafil 7)
Address1 (Sildenafil 8)
Address2 (Sildenafil 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.